For instance, in a study of 112 patients with bladder cancer, Minato et al. demonstrated that decreased GPX2 expression detected by immunohistochemistry in pathology specimens might be associated with cancer invasion [10]. The gene discussed is GPX2; the disease is urinary bladder cancer.